Thijs de Rooij1, Marc G Besselink2, Awad Shamali3, Giovanni Butturini4, Olivier R Busch1, Bjørn Edwin5, Roberto Troisi6, Laureano Fernández-Cruz7, Ibrahim Dagher8, Claudio Bassi4, Mohammad Abu Hilal9. 1. Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. 2. Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: m.g.besselink@amc.nl. 3. Department of Surgery, Southampton University Hospital, NHS Foundation Trust, Southampton, United Kingdom. 4. Department of Surgery, Verona University Hospital Trust, Verona, Italy. 5. Interventional Centre and Department of HPB Surgery, Oslo University Hospital and Institute for Clinical Medicine, Oslo University, Oslo, Norway. 6. Department of Surgery, Ghent University Hospital, Ghent, Belgium. 7. Department of Surgery, Barcelona University Hospital, Barcelona, Spain. 8. Department of Surgery, Antoine Béclère Hospital, Paris-Sud University, Paris, France. 9. Department of Surgery, Southampton University Hospital, NHS Foundation Trust, Southampton, United Kingdom. Electronic address: abuhilal9@gmail.com.
Abstract
BACKGROUND: Minimally invasive (MI) pancreatic surgery appears to be gaining popularity, but its implementation throughout Europe and the opinions regarding its use in pancreatic cancer patients are unknown. METHODS: A 30-question survey was sent between June and December 2014 to pancreatic surgeons of the European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association and 5 European national pancreatic societies. Incomplete responses were excluded. RESULTS: In total, 237 pancreatic surgeons responded. After excluding 34 incomplete responses, 203 responses from 27 European countries were included. 164 (81%) surgeons were employed at a university hospital, 184 (91%) performed advanced MI surgery and 148 (73%) performed MI distal pancreatectomy. MI pancreatoduodenectomy was performed by 42 (21%) surgeons, whereas 9 (4.4%) surgeons had performed more than 10 procedures. Robot-assisted MI pancreatic surgery was performed by 28 (14%) surgeons. 63 (31%) surgeons expected MI distal pancreatectomy for cancer to be inferior to open distal pancreatectomy concerning oncological outcomes. 151 (74%) surgeons expected to benefit from training in MI distal pancreatectomy and 149 (73%) were willing to participate in a randomized trial on this topic. CONCLUSIONS: MI distal pancreatectomy is a common procedure, although its use for cancer is still disputed. MI pancreatoduodenectomy is still an uncommon procedure. Specific training and a randomized trial regarding MI pancreatic cancer surgery are welcomed.
BACKGROUND: Minimally invasive (MI) pancreatic surgery appears to be gaining popularity, but its implementation throughout Europe and the opinions regarding its use in pancreatic cancerpatients are unknown. METHODS: A 30-question survey was sent between June and December 2014 to pancreatic surgeons of the European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association and 5 European national pancreatic societies. Incomplete responses were excluded. RESULTS: In total, 237 pancreatic surgeons responded. After excluding 34 incomplete responses, 203 responses from 27 European countries were included. 164 (81%) surgeons were employed at a university hospital, 184 (91%) performed advanced MI surgery and 148 (73%) performed MI distal pancreatectomy. MI pancreatoduodenectomy was performed by 42 (21%) surgeons, whereas 9 (4.4%) surgeons had performed more than 10 procedures. Robot-assisted MI pancreatic surgery was performed by 28 (14%) surgeons. 63 (31%) surgeons expected MI distal pancreatectomy for cancer to be inferior to open distal pancreatectomy concerning oncological outcomes. 151 (74%) surgeons expected to benefit from training in MI distal pancreatectomy and 149 (73%) were willing to participate in a randomized trial on this topic. CONCLUSIONS: MI distal pancreatectomy is a common procedure, although its use for cancer is still disputed. MI pancreatoduodenectomy is still an uncommon procedure. Specific training and a randomized trial regarding MI pancreatic cancer surgery are welcomed.
Authors: Mohammad Abu Hilal; Mohammed Hamdan; Francesco Di Fabio; Neil W Pearce; Colin D Johnson Journal: Surg Endosc Date: 2011-12-17 Impact factor: 4.584
Authors: Raghunandan Venkat; Barish H Edil; Richard D Schulick; Anne O Lidor; Martin A Makary; Christopher L Wolfgang Journal: Ann Surg Date: 2012-06 Impact factor: 12.969
Authors: Joshua A Waters; David F Canal; Eric A Wiebke; Ryan P Dumas; Joal D Beane; Juan R Aguilar-Saavedra; Chad G Ball; Michael G House; Nicholas J Zyromski; Attila Nakeeb; Henry A Pitt; Keith D Lillemoe; C Max Schmidt Journal: Surgery Date: 2010-08-24 Impact factor: 3.982
Authors: David A Kooby; William G Hawkins; C Max Schmidt; Sharon M Weber; David J Bentrem; Theresa W Gillespie; Johnita Byrd Sellers; Nipun B Merchant; Charles R Scoggins; Robert C G Martin; Hong Jin Kim; Syed Ahmad; Clifford S Cho; Alexander A Parikh; Carrie K Chu; Nicholas A Hamilton; Courtney J Doyle; Scott Pinchot; Amanda Hayman; Rebecca McClaine; Attila Nakeeb; Charles A Staley; Kelly M McMasters; Keith D Lillemoe Journal: J Am Coll Surg Date: 2010-05 Impact factor: 6.113
Authors: Armando Rosales-Velderrain; Steven P Bowers; Ross F Goldberg; Tatyan M Clarke; Mauricia A Buchanan; John A Stauffer; Horacio J Asbun Journal: World J Gastroenterol Date: 2012-08-28 Impact factor: 5.742
Authors: William B Lyman; Michael Passeri; Amit Sastry; Allyson Cochran; David A Iannitti; Dionisios Vrochides; Erin H Baker; John B Martinie Journal: Surg Endosc Date: 2018-11-12 Impact factor: 4.584
Authors: Matteo De Pastena; Jony van Hilst; Thijs de Rooij; Olivier R Busch; Michael F Gerhards; Sebastiaan Festen; Marc G Besselink Journal: J Vis Exp Date: 2018-06-17 Impact factor: 1.355
Authors: Bjørn Edwin; Mushegh A Sahakyan; Mohammad Abu Hilal; Marc G Besselink; Marco Braga; Jean-Michel Fabre; Laureano Fernández-Cruz; Brice Gayet; Song Cheol Kim; Igor E Khatkov Journal: Surg Endosc Date: 2017-02-15 Impact factor: 4.584
Authors: Michał Pędziwiatr; Piotr Małczak; Piotr Major; Jan Witowski; Beata Kuśnierz-Cabala; Piotr Ceranowicz; Andrzej Budzyński Journal: Med Oncol Date: 2017-06-01 Impact factor: 3.064
Authors: M Korrel; S Lof; J van Hilst; A Alseidi; U Boggi; O R Busch; S van Dieren; B Edwin; D Fuks; T Hackert; T Keck; I Khatkov; G Malleo; I Poves; M A Sahakyan; C Bassi; M Abu Hilal; M G Besselink Journal: Ann Surg Oncol Date: 2020-06-25 Impact factor: 5.344